News
Highly Accomplished Pharmaceutical Leader, Riad El-Dada, Further Enhances Board Expertise

3 December 2024

News
Peer-reviewed article highlights potential treatment for OLP with focus on localized drug delivery

3 December 2024

News
· Oncocyte first to published randomized interventional data to rule-in for biopsy in high-risk patient population

3 December 2024

News
Next Phase Pilot Study

2 December 2024

News
Company continues to advance its placental-derived product portfolio with the first patent granted in the fenestrated wound care market

25 November 2024

News
Company advancing late-stage clinical programs with novel therapies that target underserved heart diseases

13 November 2024

News
· Transplant centers representing about 9% of German transplant volumes and about 2% of U.S. transplant volumes have signed on to use GraftAssure kitted research test in early launch phase

12 November 2024

News
PITTSBURGH, November 12, 2024 - PRISM MediaWire - Lipella Pharmaceuticals Inc. (Nasdaq: LIPO), a clinical-stage biotechnology company focused on developing innovative therapies for serious diseases with unmet medical needs, today announced that U.S. Patent No. 12,138,345...

12 November 2024

News
Mankato, MN, October 30, 2024 - PRISM MediaWire - Digital Utilities Ventures (OTC: DUTV) is pleased to announce the significant expansion of its sales force for its innovative modular Easy Nano Void Water Clean Up and Easy FEN Liquid Microbial Growth Systems. The Easy Na...

30 October 2024

The ThinkEquity Conference 2024
St. Louis, Missouri, October 28, 2024 - PRISM MediaWire - Immunophotonics, Inc. a clinical-stage biotech company focused on the discovery and development of novel immune-activating drugs, today announced that it will be participating in The ThinkEquity Conference on Octo...

28 October 2024

1
2
3
4
5
6
7
We use cookies to run our website, analyze your use of our services, manage your online preference & personalize ad content. By accepting our cookies, you’ll get relevant content and social media features, personalized ads, and an enhanced browsing experience. To manage your choices, click „Cookie Settings”. Necessary cookies are required for the core website functionality and cannot be rejected. For more information, see our Cookie Policy.
Cookie settings
Cookies used on the site are categorized and below you can read about each category and allow or deny some or all of them, except for Necessary Cookies which are required to provide core website functionality. When categories that have been previously allowed are disabled, all cookies assigned to that category will be removed from your browser. You can see a list of cookies assigned to each category and detailed information on those cookies in the “Cookie Policy” tab.
Necessary cookies
Some cookies are required to provide core functionality. The website won't function properly without these cookies and they are enabled by default and cannot be disabled.
Preferences
Preference cookies enables the website to remember information to customize how the website looks or behaves for each user. This may include storing selected currency region, language or color theme.
Analytical cookies
Analytical cookies help us improve our website by collecting and reporting information on its usage.
Marketing cookies
Marketing cookies are used to track visitors across websites to allow publishers to display relevant and engaging advertisements. By enabling marketing cookies, you grant permission for personalized advertising across various platforms.